Synthesis and biological evaluation of chalcones having heterosubstituent(s)

Sweety, S. Kumar, K. Nepali, S. Sapra, O. P. Suri, K. L. Dhar, G. S. Sarma, A. K. Saxena

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Chalcones and their synthetic analogues appear to have the same binding site of tubuline as phenstatin, combretastatin steganacin and podophylotoxin and are therefore capable to inhibit cancer cell proliferation. The phenyl rings with appropriate substitutions maintain a fixed distance between two centers of aryl rings. The two aromatic rings in these molecules are arranged like the two wings of a butterfly having certain dihedral angle between them, therefore a "butterfly model" is proposed an important structural feature responsible for their antitubulin activity. In this sequence a series of chalcones were synthesized and evaluated for in vitro cytotoxic activity against a panel of human cancer cell lines. In addition the synthetics reduced MIC of ciprofloxacin upto four fold this indicates their bioavailability enhancing potential.

Original languageEnglish
Pages (from-to)801-806
Number of pages6
JournalIndian Journal of Pharmaceutical Sciences
Volume72
Issue number6
DOIs
Publication statusPublished - Nov 1 2010

Fingerprint

Chalcones
Butterflies
Ciprofloxacin
Biological Availability
Neoplasms
Binding Sites
Cell Proliferation
Cell Line
combretastatin
In Vitro Techniques
steganacin

Keywords

  • Antimicrobial
  • chalcones
  • in vitro cytotoxicity

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Synthesis and biological evaluation of chalcones having heterosubstituent(s). / Sweety; Kumar, S.; Nepali, K.; Sapra, S.; Suri, O. P.; Dhar, K. L.; Sarma, G. S.; Saxena, A. K.

In: Indian Journal of Pharmaceutical Sciences, Vol. 72, No. 6, 01.11.2010, p. 801-806.

Research output: Contribution to journalArticle

Sweety, Kumar, S, Nepali, K, Sapra, S, Suri, OP, Dhar, KL, Sarma, GS & Saxena, AK 2010, 'Synthesis and biological evaluation of chalcones having heterosubstituent(s)', Indian Journal of Pharmaceutical Sciences, vol. 72, no. 6, pp. 801-806. https://doi.org/10.4103/0250-474X.84602
Sweety ; Kumar, S. ; Nepali, K. ; Sapra, S. ; Suri, O. P. ; Dhar, K. L. ; Sarma, G. S. ; Saxena, A. K. / Synthesis and biological evaluation of chalcones having heterosubstituent(s). In: Indian Journal of Pharmaceutical Sciences. 2010 ; Vol. 72, No. 6. pp. 801-806.
@article{1fbe3752deb64a598d3bda862f7c2916,
title = "Synthesis and biological evaluation of chalcones having heterosubstituent(s)",
abstract = "Chalcones and their synthetic analogues appear to have the same binding site of tubuline as phenstatin, combretastatin steganacin and podophylotoxin and are therefore capable to inhibit cancer cell proliferation. The phenyl rings with appropriate substitutions maintain a fixed distance between two centers of aryl rings. The two aromatic rings in these molecules are arranged like the two wings of a butterfly having certain dihedral angle between them, therefore a {"}butterfly model{"} is proposed an important structural feature responsible for their antitubulin activity. In this sequence a series of chalcones were synthesized and evaluated for in vitro cytotoxic activity against a panel of human cancer cell lines. In addition the synthetics reduced MIC of ciprofloxacin upto four fold this indicates their bioavailability enhancing potential.",
keywords = "Antimicrobial, chalcones, in vitro cytotoxicity",
author = "Sweety and S. Kumar and K. Nepali and S. Sapra and Suri, {O. P.} and Dhar, {K. L.} and Sarma, {G. S.} and Saxena, {A. K.}",
year = "2010",
month = "11",
day = "1",
doi = "10.4103/0250-474X.84602",
language = "English",
volume = "72",
pages = "801--806",
journal = "Indian Journal of Pharmaceutical Sciences",
issn = "0250-474X",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "6",

}

TY - JOUR

T1 - Synthesis and biological evaluation of chalcones having heterosubstituent(s)

AU - Sweety,

AU - Kumar, S.

AU - Nepali, K.

AU - Sapra, S.

AU - Suri, O. P.

AU - Dhar, K. L.

AU - Sarma, G. S.

AU - Saxena, A. K.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Chalcones and their synthetic analogues appear to have the same binding site of tubuline as phenstatin, combretastatin steganacin and podophylotoxin and are therefore capable to inhibit cancer cell proliferation. The phenyl rings with appropriate substitutions maintain a fixed distance between two centers of aryl rings. The two aromatic rings in these molecules are arranged like the two wings of a butterfly having certain dihedral angle between them, therefore a "butterfly model" is proposed an important structural feature responsible for their antitubulin activity. In this sequence a series of chalcones were synthesized and evaluated for in vitro cytotoxic activity against a panel of human cancer cell lines. In addition the synthetics reduced MIC of ciprofloxacin upto four fold this indicates their bioavailability enhancing potential.

AB - Chalcones and their synthetic analogues appear to have the same binding site of tubuline as phenstatin, combretastatin steganacin and podophylotoxin and are therefore capable to inhibit cancer cell proliferation. The phenyl rings with appropriate substitutions maintain a fixed distance between two centers of aryl rings. The two aromatic rings in these molecules are arranged like the two wings of a butterfly having certain dihedral angle between them, therefore a "butterfly model" is proposed an important structural feature responsible for their antitubulin activity. In this sequence a series of chalcones were synthesized and evaluated for in vitro cytotoxic activity against a panel of human cancer cell lines. In addition the synthetics reduced MIC of ciprofloxacin upto four fold this indicates their bioavailability enhancing potential.

KW - Antimicrobial

KW - chalcones

KW - in vitro cytotoxicity

UR - http://www.scopus.com/inward/record.url?scp=80052910372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052910372&partnerID=8YFLogxK

U2 - 10.4103/0250-474X.84602

DO - 10.4103/0250-474X.84602

M3 - Article

AN - SCOPUS:80052910372

VL - 72

SP - 801

EP - 806

JO - Indian Journal of Pharmaceutical Sciences

JF - Indian Journal of Pharmaceutical Sciences

SN - 0250-474X

IS - 6

ER -